Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's
Go back to Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 32.20 +0.72 (2.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.48 | 52 Week High | $66.55 | |||
| Open | $31.37 | 52 Week Low | $37.82 | |||
| Day High | $32.39 | P/E | N/A | |||
| Day Low | $31.28 | EPS | $0.00 | |||
| Volume | 6,111,090 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 32.20 +0.72 (2.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.48 | 52 Week High | $66.55 | |||
| Open | $31.37 | 52 Week Low | $37.82 | |||
| Day High | $32.39 | P/E | N/A | |||
| Day Low | $31.28 | EPS | $0.00 | |||
| Volume | 6,111,090 | |||||

